Category - Pharma Industry News
Early promise for new immunotherapy combo in brain cancer
Farxiga fails to achieve statistical significance in COVID-19 trial
Keytruda shows significant and meaningfully improvement in kidney cancer
EU nod for new formulation of Biogen’s Tysabri
NICE ‘no’ for Opdivo/Yervoy lung cancer combo
Human trials for world’s first AI-designed immuno-oncology drug
Lilly, Incyte’s Olumiant fails in COVID-19 trial
Alternatives to AZ vaccine should be offered to those under 30 in the UK